Schizoaffective Disorders Withdrawn Phase 3 Trials for Olanzapine (DB00334)
Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0033299 (Schizoaffective Disorders) | Withdrawn | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00440843 | Zyprexa and Task Engagement in Schizophrenia | Treatment |